• SoLVBL Solution (SOLV) has announced a product development agreement with Bit Complete Inc.
  • Bit Complete will develop an administrative web application for SoLVBL’s cybersecurity and data authentication products
  • SoLVBL is ready to develop its Q Admin software in collaboration with Bit Complete
  • Kaiser Akbar, President & CEO of SoLVBL, sat down with Daniella Atkinson to discuss the partnership
  • Bit Complete is a Toronto-based digital product design and development company
  • SoLVBL is a cybersecurity and data authentication company
  • SoLVBL Solutions Inc. (SOLV) opened trading at C$0.05

SoLVBL Solution (SOLV) has announced a product development agreement with Bit Complete Inc.

Under the agreement, Bit Complete will develop an administrative web application for SoLVBL’s cybersecurity and data authentication products.

Jim Slinowsky, head of product development for SoLVBL, will lead the software development in collaboration with Bit Complete. With the product design, including unique user experience, wire-framing and high-fidelity design prototypes completed, SoLVBL is ready to develop its Q Admin software in collaboration with Bit Complete. This will allow SoLVBL to ensure the new cybersecurity products are supported by a best-in-class onboarding and account management experience.

Kaiser Akbar, President & CEO of SoLVBL, sat down with Daniella Atkinson to discuss the partnership with Bit Complete.

“We are very excited to be working with Bit Complete to develop an enhanced, scalable and intuitive account management application for our institutional and corporate clients,” said Kaiser Akbar, President & CEO of SoLVBL.

Bit Complete is a Toronto-based digital product design and development company. 

SoLVBL is a cybersecurity and data authentication company. Q by SoLVBL is a proprietary technology platform designed to provide digital record authentication at high speed.

SoLVBL Solutions Inc. (SOLV) opened trading at C$0.05. 


More From The Market Online

Armored steel meets swarm intelligence: Why Rheinmetall and Hensoldt must retool – and why NEO Battery Materials could become a hidden winner of the drone war

The war in Ukraine has shattered military doctrines that were considered irrefutable in NATO headquarters for...

An immunotherapy value play advancing the fight against bladder cancer

An in-depth look at BioVaxys Technology (CSE:BIOV), a micro-cap stock combining a promising drug pipeline with irrational investor pessimism.